优化前列腺癌患者的（18）F-胆碱PET/CT采集方案 - Suppr

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients.

作者信息

Massaro Arianna, Ferretti Alice, Secchiero Chiara, Cittadin Silvia, Milan Elisa, Tamiso Luca, Pavan Lara, Tommasi Enrico, Marzola Maria Cristina, Chondrogiannis Sotirios, Rampin Lucia, Marcolongo Adriano, Rubello Domenico

机构信息

Service of Nuclear Medicine, PET Centre, Santa Maria Della Misericordia Hospital, Rovigo, Italy. E-mail:

出版信息

N Am J Med Sci. 2012 Sep;4(9):416-20. doi: 10.4103/1947-2714.100994.

DOI:10.4103/1947-2714.100994

PMID:23050255

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3456485/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f9/3456485/1bda5ccf9769/NAJMS-4-416-g005.jpg

相似文献

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients.

N Am J Med Sci. 2012 Sep;4(9):416-20. doi: 10.4103/1947-2714.100994.

More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

F-Choline PET/CT scan in staging and biochemical recurrence in prostate cancer patients: Changes in classification and radiotherapy planning.

Rev Esp Med Nucl Imagen Mol. 2017 Sep-Oct;36(5):292-297. doi: 10.1016/j.remn.2017.02.007. Epub 2017 Mar 31.

Acquisition with (11)C-choline and (18)F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.

Ann Nucl Med. 2016 Jul;30(6):385-92. doi: 10.1007/s12149-016-1078-7. Epub 2016 May 12.

New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization.

Biomed Res Int. 2014;2014:215650. doi: 10.1155/2014/215650. Epub 2014 Jul 10.

Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.

J Nucl Med. 2013 Jun;54(6):833-40. doi: 10.2967/jnumed.112.110148. Epub 2013 Apr 4.

Diagnostic performance of a streamlined F-choline PET-CT protocol for the detection of prostate carcinoma recurrence in combination with appropriate-use criteria.

Clin Radiol. 2018 Jul;73(7):632-639. doi: 10.1016/j.crad.2018.03.018. Epub 2018 Apr 30.

Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive cases.

Clin Nucl Med. 2015 Jun;40(6):e308-12. doi: 10.1097/RLU.0000000000000757.

Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.

World J Urol. 2015 Oct;33(10):1511-8. doi: 10.1007/s00345-015-1481-z. Epub 2015 Jan 11.

Impact of pelvic dynamic acquisition on final reading of F-Fluorocholine positron emission tomography in patients with prostate adenocarcinoma: True need or unnecessary burden?

J Med Imaging Radiat Oncol. 2022 Apr;66(3):324-331. doi: 10.1111/1754-9485.13296. Epub 2021 Jul 29.

引用本文的文献

Biologically-Based Mathematical Modeling of Tumor Vasculature and Angiogenesis via Time-Resolved Imaging Data.

Cancers (Basel). 2021 Jun 16;13(12):3008. doi: 10.3390/cancers13123008.

Assessment and Comparison of F-Fluorocholine PET and Tc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis.

J Nucl Med. 2021 Sep 1;62(9):1285-1291. doi: 10.2967/jnumed.120.257303. Epub 2021 Jan 15.

A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis.

Diagnostics (Basel). 2020 Dec 24;11(1):17. doi: 10.3390/diagnostics11010017.

Optimization of temporal sampling for F-choline uptake quantification in prostate cancer assessment.

EJNMMI Res. 2018 Jun 15;8(1):49. doi: 10.1186/s13550-018-0410-8.

[F]Fluoromisonidazole PET in rectal cancer.

EJNMMI Res. 2017 Sep 20;7(1):78. doi: 10.1186/s13550-017-0324-x.

The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents.

J Nucl Med. 2016 Dec;57(12):2022-2026. doi: 10.2967/jnumed.116.178814. Epub 2016 Jul 21.

New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization.

Biomed Res Int. 2014;2014:215650. doi: 10.1155/2014/215650. Epub 2014 Jul 10.

Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1293-300. doi: 10.1007/s00259-014-2720-z. Epub 2014 Feb 25.

First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):68-78. doi: 10.1007/s00259-013-2540-6. Epub 2013 Oct 9.

Role of ¹⁸F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer.

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1356-64. doi: 10.1007/s00259-013-2433-8. Epub 2013 May 14.

本文引用的文献

[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.

Radiat Oncol. 2011 May 1;6:44. doi: 10.1186/1748-717X-6-44.

Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer.

Nucl Med Commun. 2011 Jun;32(6):475-8. doi: 10.1097/MNM.0b013e3283455765.

Global cancer statistics.

CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.

Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.

J Nucl Med. 2011 Jan;52(1):81-9. doi: 10.2967/jnumed.110.077941. Epub 2010 Dec 13.

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):301-9. doi: 10.1007/s00259-009-1253-3. Epub 2009 Sep 15.

The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Ann ICRP. 2007;37(2-4):1-332. doi: 10.1016/j.icrp.2007.10.003.

Managing patient dose in multi-detector computed tomography(MDCT). ICRP Publication 102.

Ann ICRP. 2007;37(1):1-79, iii. doi: 10.1016/j.icrp.2007.09.001.

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):253-63. doi: 10.1007/s00259-007-0552-9. Epub 2007 Oct 10.

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.

Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):9-17. doi: 10.1007/s00259-007-0530-2. Epub 2007 Sep 9.

Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.

J Urol. 2006 Nov;176(5):2014-8; discussion 2018-9. doi: 10.1016/j.juro.2006.07.037.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献